Cross-protection against a lethal influenza virus infection by DNA vaccine to neuraminidase

By Chen Z.   Kadowaki S.-E.   Hagiwara Y.   Yoshikawa T.   Matsuo K.   Kurata T.   Tamura S.-I.  

Vaccine, Vol. 18, Iss. 28, 2000-08 ,pp. : 3214-3222

Elsevier

Access to resources Recommend Favorite

An inactivated bovine virus diarrhoea virus (BVDV) type 1 vaccine affords clinical protection against BVDV type 2

By Makoschey B.   Janssen M.G.J.   Vrijenhoek M.P.   Korsten J.H.M.   Marel P.v.d.  

Vaccine, Vol. 19, Iss. 23, 2001-04 ,pp. : 3261-3268

Elsevier

Access to resources Recommend Favorite

Vaccine-induced cytotoxic T lymphocytes against human immunodeficiency virus type 1 using two complementary in vitro stimulation strategies

By Gorse G.J.   Patel G.B.   Mandava M.D.   Belshe R.B.  

Vaccine, Vol. 18, Iss. 9, 1999-12 ,pp. : 835-849

Elsevier

Access to resources Recommend Favorite

Cross-protective efficacy of a bovine viral diarrhea virus (BVDV) type 1 vaccine against BVDV type 2 challenge

By Dean H.J.   Leyh R.  

Vaccine, Vol. 17, Iss. 9, 1999-03 ,pp. : 1117-1124

Elsevier

Access to resources Recommend Favorite

Protection against lethal Japanese encephalitis virus infection of mice by immunization with the highly attenuated MVA strain of vaccinia virus expressing JEV prM and E genes

By Nam J.-H.   Wyatt L.S.   Chae S.-L.   Cho H.-W.   Park Y.-K.   Moss B.  

Vaccine, Vol. 17, Iss. 3, 1999-02 ,pp. : 261-268

Elsevier

Access to resources Recommend Favorite